Overview
Description
Renalytix AI Plc is a data-driven diagnostic company that operates in the healthcare sector, specifically focusing on kidney disease. The primary function of Renalytix AI Plc is to deploy advanced artificial intelligence solutions to enhance the early detection and management of chronic kidney diseases. This innovation is integral for healthcare providers striving to improve patient outcomes and reduce the economic burden of kidney-related ailments. The company is best known for its KidneyIntelX platform, a system that leverages proprietary algorithms to stratify patients' risk based on their kidney disease progression. By integrating data from clinical records, genomics, and other pertinent sources, Renalytix AI aims to provide actionable insights that assist doctors in making informed treatment decisions. Holding a prominent place in healthcare innovation, the company significantly impacts sectors concerned with disease prevention, patient safety, and healthcare costs. Given the rising prevalence of kidney disease worldwide, Renalytix AI Plc serves a crucial role in transforming kidney care through technology.
About
CEO
Mr. James R. McCullough M.B.A.
Employees
0
Address
1460 Broadway
New York, 10036, NY
United States
New York, 10036, NY
United States
Phone
646 397 3970
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Health Information Services
Country
Germany
MIC code
XMUN